Eton Pharmaceuticals, Inc. ETON Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s inventory write-downs?
- Eton Pharmaceuticals, Inc. (ETON) reported inventory write-downs of $227K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s inventory write-downs changed year-over-year?
- Eton Pharmaceuticals, Inc.'s inventory write-downs increased by 106.4% year-over-year, from $110K to $227K.
- What does inventory write-downs mean?
- Reflects the reduction in the carrying value of inventory when its market value falls below its recorded cost due to obsolescence, spoilage, or lack of demand. This non-cash charge indicates potential inefficiencies in inventory management or shifts in product marketability. Monitoring this helps investors assess the quality of inventory and the risk of future margin compression.